1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (011) 886 228739318
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy
Article first published online: 17 MAY 2006
DOI: 10.1002/cncr.21972
Copyright © 2006 American Cancer Society
Additional Information
How to Cite
Huo, T.-I., Lin, H.-C., Huang, Y.-H., Wu, J.-C., Chiang, J.-H., Lee, P.-C. and Lee, S.-D. (2006), The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer, 107: 141–148. doi: 10.1002/cncr.21972
- †
Fax: (011) 886 228739318
Publication History
- Issue published online: 16 JUN 2006
- Article first published online: 17 MAY 2006
- Manuscript Accepted: 27 MAR 2006
- Manuscript Revised: 18 JAN 2006
- Manuscript Received: 28 NOV 2005
Funded by
- National Science Council, Executive Yuan, Taiwan. Grant Number: NSC 94-2314-B-010-049
REFERENCES
- 1, , , et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003; 139: 817–823.
- 2, , , et al. Hepatocellular carcinoma. Ann Oncol. 2001; 12: 161–172.
- 3, , , et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology. 2005; 41: 707–715.
- 4, , . Staging for hepatocellular carcinoma: look for a perfect classification system. J Hepatol. 2004; 40: 1041–1042.
- 5, . Staging for hepatocellular carcinoma: treatment strategy matters. Hepatology. 2005; 41: 678.
- 6The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology. 2000; 31: 840–845.
- 7, . A common staging system for hepatocellular carcinoma. Hepatology. 2004; 39: 550–551.Direct Link:
- 8, , , et al. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology. 2004; 40: 1396–1405.
- 9, , , et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol. 2005; 100: 1764–1771.Direct Link:
- 10, , , et al. The United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology. 2003; 124: 91–96.
- 11, , , et al. Improving liver allocation: MELD and PELD. Am J Transplant. 2004; 4( Suppl 9): 114–131.
- 12, , , et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl. 2004; 10(10 Suppl 2 ): A6–A22.
- 13, , , et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003; 52: 134–139.
- 14, , , et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol. 2002; 36: 494–500.
- 15, , , et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol. 2001; 35: 421–430.
- 16, , , et al. Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-Stage Liver Disease (MELD), in predicting outcome after treatment. Aliment Pharmacol Ther. 2003; 17: 1563–1569.
- 17, , , et al. The safety of intra-abdominal surgery in patients with cirrhosis: Model for End-Stage Liver Disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg. 2005; 140: 650–654.
- 18, , , et al. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. Scand J Gastroenterol. 2003; 38: 770–778.
- 19, , , et al. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey. Aliment Pharmacol Ther. 2004; 19: 1391–1398.
- 20, . The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143: 29–36.
- 21, . A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983; 148: 839–843.
- 22, , , . A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997; 16: 965–980.
- 23. Clinical biostatistics XVI. The process of prognostic stratification. Clin Pharmacol Ther. 1972; 13: 609–624.
- 24. Key concepts in model selection: performance and generalizability. J Math Psychol. 2000; 44: 205–231.
- 25, , , et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004; 40: 897–903.
- 26, , , et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005; 41: 353–358.
- 27, , , et al. The survival benefit of liver transplantation. Am J Transplant. 2005; 5: 307–313.
- 28. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection. Liver Transpl. 2004; 10(10 Suppl 2 ): S2–S3.
- 29, , , et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003; 52: 879–885.
- 30, , , et al. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg. 2004; 188: 580–583.
- 31, , , et al. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005; 242: 244–251.
- 32, , , et al. Reliability of contemporary radiology to measure tumor size of hepatocellular carcinoma in patients undergoing resection: limitations and clinical implications. Scand J Gastroenterol. 2004; 39: 46–52.
- 33, , . Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999; 19: 329–338.
- 34GreeneFL, PageDL, FlemingID, et al., editors. The AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
- 35, , , et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol. 2004; 40: 124–131.
- 36, , , et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol. 2005; 100: 1764–1771.Direct Link:
- 37, , , et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer. 2002; 94: 1760–1769.
- 38, , , et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334: 693–699.
- 39, , , et al. Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer. 2003; 97: 1042–1050.
- 40, . Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005; 42( Suppl 1): S100–S107.